Invenomic Capital Management LP Trims Position in Dun & Bradstreet Holdings, Inc. (NYSE:DNB)

Invenomic Capital Management LP decreased its position in shares of Dun & Bradstreet Holdings, Inc. (NYSE:DNB - Free Report) by 17.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,812,722 shares of the business services provider's stock after selling 378,078 shares during the quarter. Dun & Bradstreet makes up about 1.1% of Invenomic Capital Management LP's holdings, making the stock its 21st largest position. Invenomic Capital Management LP owned 0.41% of Dun & Bradstreet worth $22,587,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in DNB. Amundi raised its stake in shares of Dun & Bradstreet by 27.9% during the fourth quarter. Amundi now owns 5,158 shares of the business services provider's stock worth $64,000 after purchasing an additional 1,126 shares during the last quarter. Cetera Investment Advisers raised its position in Dun & Bradstreet by 5.5% during the 4th quarter. Cetera Investment Advisers now owns 23,843 shares of the business services provider's stock worth $297,000 after buying an additional 1,240 shares during the last quarter. Xponance Inc. raised its position in Dun & Bradstreet by 16.5% during the 4th quarter. Xponance Inc. now owns 13,252 shares of the business services provider's stock worth $165,000 after buying an additional 1,881 shares during the last quarter. Cerity Partners LLC lifted its stake in shares of Dun & Bradstreet by 10.1% in the 4th quarter. Cerity Partners LLC now owns 20,771 shares of the business services provider's stock worth $259,000 after acquiring an additional 1,909 shares during the period. Finally, Truist Financial Corp increased its stake in shares of Dun & Bradstreet by 8.7% during the fourth quarter. Truist Financial Corp now owns 24,420 shares of the business services provider's stock worth $304,000 after acquiring an additional 1,958 shares during the period. Institutional investors and hedge funds own 86.68% of the company's stock.

Insider Transactions at Dun & Bradstreet

In other news, Chairman William P. Foley II sold 2,500,000 shares of the business's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $8.96, for a total value of $22,400,000.00. Following the completion of the transaction, the chairman now directly owns 5,609,644 shares of the company's stock, valued at $50,262,410.24. The trade was a 30.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Chinh Chu sold 10,885,403 shares of the company's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $8.95, for a total value of $97,424,356.85. Following the completion of the sale, the director now owns 23,810 shares in the company, valued at $213,099.50. This represents a 99.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,885,403 shares of company stock valued at $142,299,357 in the last 90 days. 10.44% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on DNB. Needham & Company LLC restated a "hold" rating on shares of Dun & Bradstreet in a research report on Friday, May 2nd. Royal Bank of Canada reissued a "sector perform" rating and issued a $12.00 price target on shares of Dun & Bradstreet in a report on Wednesday, January 29th. The Goldman Sachs Group decreased their price target on Dun & Bradstreet from $12.80 to $11.00 and set a "neutral" rating on the stock in a research note on Friday, February 21st. Jefferies Financial Group reiterated a "hold" rating and issued a $9.15 price objective (down previously from $11.00) on shares of Dun & Bradstreet in a research report on Tuesday, March 25th. Finally, StockNews.com assumed coverage on Dun & Bradstreet in a report on Tuesday. They issued a "hold" rating for the company. Seven research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $11.86.

Dun & Bradstreet Price Performance

Shares of DNB stock traded up $0.01 during midday trading on Wednesday, reaching $8.98. 4,048,928 shares of the company traded hands, compared to its average volume of 6,030,337. The firm's 50 day simple moving average is $8.75 and its two-hundred day simple moving average is $10.60. The firm has a market cap of $4.01 billion, a PE ratio of -149.64, a price-to-earnings-growth ratio of 2.21 and a beta of 1.14. The company has a debt-to-equity ratio of 1.06, a current ratio of 0.65 and a quick ratio of 0.70. Dun & Bradstreet Holdings, Inc. has a 1-year low of $7.78 and a 1-year high of $12.95.

Dun & Bradstreet (NYSE:DNB - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.01. The firm had revenue of $579.80 million during the quarter, compared to the consensus estimate of $578.02 million. Dun & Bradstreet had a positive return on equity of 11.29% and a negative net margin of 1.20%. Dun & Bradstreet's quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the business posted $0.20 EPS. On average, equities research analysts expect that Dun & Bradstreet Holdings, Inc. will post 0.96 EPS for the current fiscal year.

Dun & Bradstreet Profile

Dun & Bradstreet Holdings, Inc engages in providing business decisioning data and analytics solutions. The firm is involved in providing information with its solutions to support its clients with critical business operations. It offers end-to-end solutions to clients in the small business, finance, sales & marketing, third party risk & compliance, and public sectors.